Comparison of cardiac samples from heart failure patients with different disease severity (ranging from NYHA class I to IV) showed increased Ca2+ sensitivity only in the end-stage (NYHA class IV) of cardiac disease [25], which suggested that detrimental effects of reduced cTnI phosphorylation may only become evident at the end-stage of heart failure. This evidence concerns the gene TNNI3 and heart disorder.